Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENAT: Nutrition and Infection Treatment in Pregnancy (Ethiopia)
NCT04171388Phase 4Withdrawn
- Sponsor
- Brigham and Women's Hospital
- Start
- Mar 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of azithromycin in low birth weight (LBW) and preterm birth (6 arms), sponsored by Brigham and Women's Hospital. Primary endpoints: Birth weight at 72 hours and Birth length at 72 hours. Planned start Mar 2020; status: withdrawn.
02
Drugs
azithromycin
03
Conditions
low birth weight (LBW)preterm birth
Beyond the preview
Go deeper on NCT04171388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04171388.